Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 125Lymphoid 26Gastrointestinal 26Genitourinary 21CNS 21Other hematologic neoplasm 20Sarcoma 16Thoracic 14Dermatologic 11Myeloid 7Gynecologic 6Head & Neck 4Endocrine 4Classical hematology 4Other solid neoplasm 3Breast 3Tumor-Agnostic 2NET 2Other neoplasm 1

Conditions

Precancerous Conditions 1Mastocytosis, Systemic 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thalidomide × Other neoplasm × Clear all
NCT00769587 2025-09-22

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Centre Hospitalier Universitaire, Amiens

Completed
MyeloidOther neoplasm

Precancerous Conditions, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡